DE69825880D1 - Verfahren zur herstellung von eprosartan - Google Patents

Verfahren zur herstellung von eprosartan

Info

Publication number
DE69825880D1
DE69825880D1 DE69825880T DE69825880T DE69825880D1 DE 69825880 D1 DE69825880 D1 DE 69825880D1 DE 69825880 T DE69825880 T DE 69825880T DE 69825880 T DE69825880 T DE 69825880T DE 69825880 D1 DE69825880 D1 DE 69825880D1
Authority
DE
Germany
Prior art keywords
eprosartan
producing
producing eprosartan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69825880T
Other languages
English (en)
Other versions
DE69825880T2 (de
Inventor
T Matsuoka
Peng Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of DE69825880D1 publication Critical patent/DE69825880D1/de
Application granted granted Critical
Publication of DE69825880T2 publication Critical patent/DE69825880T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69825880T 1997-02-14 1998-02-13 Verfahren zur herstellung von eprosartan Expired - Lifetime DE69825880T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3819697P 1997-02-14 1997-02-14
US38196P 1997-02-14
PCT/US1998/002411 WO1998035962A1 (en) 1997-02-14 1998-02-13 Process for preparing eprosartan

Publications (2)

Publication Number Publication Date
DE69825880D1 true DE69825880D1 (de) 2004-09-30
DE69825880T2 DE69825880T2 (de) 2005-09-08

Family

ID=21898590

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69825880T Expired - Lifetime DE69825880T2 (de) 1997-02-14 1998-02-13 Verfahren zur herstellung von eprosartan

Country Status (41)

Country Link
US (2) US6294675B1 (de)
EP (1) EP0973769B1 (de)
JP (1) JP4227671B2 (de)
KR (1) KR100551667B1 (de)
CN (1) CN1093128C (de)
AP (1) AP1202A (de)
AR (1) AR011126A1 (de)
AT (1) ATE274511T1 (de)
AU (1) AU730162B2 (de)
BG (1) BG63970B1 (de)
BR (1) BRPI9808642B8 (de)
CA (1) CA2281471C (de)
CO (1) CO4950549A1 (de)
CY (1) CY2551B1 (de)
CZ (1) CZ296543B6 (de)
DE (1) DE69825880T2 (de)
DK (1) DK0973769T3 (de)
DZ (1) DZ2418A1 (de)
EA (1) EA001761B1 (de)
EG (1) EG23780A (de)
ES (1) ES2224358T3 (de)
HK (1) HK1026206A1 (de)
HU (1) HU228098B1 (de)
ID (1) ID23155A (de)
IL (4) IL131310A (de)
IN (1) IN188000B (de)
MA (1) MA24472A1 (de)
MY (1) MY120024A (de)
NO (1) NO317761B1 (de)
NZ (1) NZ337182A (de)
OA (1) OA11086A (de)
PE (1) PE59799A1 (de)
PL (1) PL192837B1 (de)
PT (1) PT973769E (de)
SA (1) SA98190146B1 (de)
SI (1) SI0973769T1 (de)
SK (1) SK285125B6 (de)
TR (1) TR199901935T2 (de)
UA (1) UA57060C2 (de)
WO (1) WO1998035962A1 (de)
ZA (1) ZA981208B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.
US6630498B2 (en) * 1997-08-06 2003-10-07 Smithkline Beecham Corporation Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation
KR100634953B1 (ko) * 1998-07-20 2006-10-17 스미스클라인 비참 코포레이션 에프로사르탄을 포함하는 생물학적으로 강화된 경구 고형투여 형태의 제제
US20060099230A1 (en) * 2004-11-10 2006-05-11 Chin-Chih Chiang Novel formulations of eprosartan with enhanced bioavailability
EP2097408A4 (de) * 2006-12-27 2010-08-25 Hetero Drugs Ltd Verbessertes verfahren für eprosartan
CN101896457A (zh) * 2007-10-22 2010-11-24 幽兰研究实验室有限公司 组蛋白脱乙酰基酶抑制剂
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
CN102584709B (zh) * 2011-12-19 2016-08-17 浙江华海药业股份有限公司 一种改进的依普罗沙坦中间体芳基咪唑醛的制备工艺
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE190051T1 (de) * 1989-06-14 2000-03-15 Smithkline Beecham Corp Imidazoalkensäure
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
JP3214856B2 (ja) * 1990-12-14 2001-10-02 スミスクライン・ビーチャム・コーポレイション イミダゾリル−アルケン酸
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.

Also Published As

Publication number Publication date
AR011126A1 (es) 2000-08-02
BR9808642A (pt) 2000-05-23
AP1202A (en) 2003-09-02
UA57060C2 (uk) 2003-06-16
HK1026206A1 (en) 2000-12-08
EA199900741A1 (ru) 2000-02-28
CN1093128C (zh) 2002-10-23
EP0973769A1 (de) 2000-01-26
SI0973769T1 (en) 2004-12-31
DK0973769T3 (da) 2004-12-13
EG23780A (en) 2007-08-13
TR199901935T2 (xx) 1999-12-21
AU6273298A (en) 1998-09-08
CZ296543B6 (cs) 2006-04-12
ATE274511T1 (de) 2004-09-15
BG63970B1 (bg) 2003-08-29
CN1247538A (zh) 2000-03-15
HUP0001813A2 (hu) 2001-06-28
IL143783A0 (en) 2002-04-21
AU730162B2 (en) 2001-03-01
BR9808642B1 (pt) 2013-11-26
CA2281471C (en) 2007-04-24
DZ2418A1 (fr) 2003-06-26
KR20000071008A (ko) 2000-11-25
IL143784A0 (en) 2002-04-21
IL143784A (en) 2005-05-17
ID23155A (id) 2000-03-23
NO993912L (no) 1999-08-13
IL143785A (en) 2004-12-15
MA24472A1 (fr) 1998-10-01
JP2001511808A (ja) 2001-08-14
BRPI9808642B8 (pt) 2021-05-25
PL192837B1 (pl) 2006-12-29
OA11086A (en) 2003-03-13
NO317761B1 (no) 2004-12-13
HUP0001813A3 (en) 2001-07-30
IL143783A (en) 2005-05-17
IL143785A0 (en) 2002-04-21
ZA981208B (en) 1998-11-12
CO4950549A1 (es) 2000-09-01
NZ337182A (en) 2001-04-27
JP4227671B2 (ja) 2009-02-18
SK285125B6 (sk) 2006-06-01
US6294675B1 (en) 2001-09-25
WO1998035962A1 (en) 1998-08-20
EP0973769B1 (de) 2004-08-25
PE59799A1 (es) 1999-08-06
MY120024A (en) 2005-08-30
PT973769E (pt) 2004-11-30
CA2281471A1 (en) 1998-08-20
EP0973769A4 (de) 2001-01-24
IL131310A (en) 2003-02-12
CY2551B1 (en) 2008-07-02
SK108699A3 (en) 2000-05-16
US6458963B1 (en) 2002-10-01
DE69825880T2 (de) 2005-09-08
HU228098B1 (en) 2012-10-29
KR100551667B1 (ko) 2006-02-13
PL335074A1 (en) 2000-04-10
ES2224358T3 (es) 2005-03-01
AP9901619A0 (en) 1999-09-30
NO993912D0 (no) 1999-08-13
BG103649A (en) 2000-06-30
IL131310A0 (en) 2001-01-28
CZ285199A3 (cs) 2000-02-16
SA98190146B1 (ar) 2006-08-20
US20020028951A1 (en) 2002-03-07
EA001761B1 (ru) 2001-08-27
IN188000B (de) 2002-08-03

Similar Documents

Publication Publication Date Title
DE69719098D1 (de) Verfahren zur herstellung von citalopram
DE69911398D1 (de) Verfahren zur herstellung von 4-aminodiphenylaminen
DE69816440D1 (de) Verfahren zur herstellung von flurbiprofen-lutschtabletten
DE69913666D1 (de) Verfahren zur herstellung von di-methyl-naphthalinen
ATE339433T1 (de) Verbessertes verfahren zur herstellung von makroliden
DE69816295D1 (de) Verfahren zur herstellung von aromatischem poycarbonat
DE59901552D1 (de) Verfahren zur herstellung von polyalkylenarylaten
ATE274511T1 (de) Verfahren zur herstellung von eprosartan
ATE280765T1 (de) Verfahren zur herstellung von eprosartan
DE69910995D1 (de) Verfahren zur herstellung von fluorkohlenwasserstoffen
DE69819191D1 (de) Verfahren zur herstellung von pentafluorethan
DE59805920D1 (de) Verfahren zur herstellung von oxazaphosphorin-2-aminen
DE69733152D1 (de) Verfahren zur herstellung von tetrazolylbenzopyranen
DE69901192D1 (de) Verfahren zur herstellung von cyclopropanmethylamin
DE59802764D1 (de) Verfahren zur herstellung von phosphabenzolverbindungen
DE69806759T2 (de) Verfahren zur herstellung von pentafluorethan
DE59903764D1 (de) Verfahren zur herstellung von phytosqualan
DE69813588D1 (de) Verfahren zur herstellung von 3-ispchromanon
DE69802546T2 (de) Verfahren zur herstellung von tuftingware
ATE273291T1 (de) Verfahren zur herstellung von chlorbenzoxazolen
DE59802548D1 (de) Verfahren zur herstellung von webware
DE59805432D1 (de) Verfahren zur herstellung von 2-cyclododecyl-1-propanol
DE59906309D1 (de) Verfahren zur herstellung von cyclohexandiaminen
ATE207901T1 (de) Verfahren zur herstellung von 2-chlor-3- hydroxypyridin
DE69808100T2 (de) Verfahren zur herstellung von 3-isochromanon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition